<DOC>
	<DOC>NCT00770523</DOC>
	<brief_summary>Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients with Hematologic Malignancies.</brief_summary>
	<brief_title>Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells</brief_title>
	<detailed_description>Primary end points are treatment-related mortality and engraftment. Secondary end points are regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients should have an unrelated donor who is matched for HLAA and B by serology and for DRB1 by molecular typing. Patients should not have major illness or organ failure Patients must not have a psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible. Patients must not be pregnant or lactating.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>patients without comorbidity</keyword>
</DOC>